Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets clinical trials

Explore recruiting systemic sclerosis ssc presenting with limited or diffuse cutaneous subsets clinical trials.

Also recruiting in Europe

Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Randomized, Parallel-group, Double-blind, Two-arm, Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared with Placebo in Male and Female Participants 18 to 70 Years of Age Inclusive with Systemic Sclerosis

Austria, Poland, Hungary, Romania, Spain, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets trials by city

Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Toronto Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Vancouver Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Montreal Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Calgary Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Edmonton Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Ottawa Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Winnipeg Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Quebec City Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Hamilton Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Kitchener Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in London Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Halifax Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in New York Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Los Angeles Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Chicago Systemic Sclerosis Ssc Presenting With Limited Or Diffuse Cutaneous Subsets in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease